-transparent.png){kind=logo}
Adding duborimycin to the association of vincristine + DTIC in the treatment of malignant melanoma produces therapeutic results interesting but not statistically significant and not counter-balancing the toxic side effects. This study confirms the lack of positive results of polychemotherapy in melanoma as compared to treatment by an efficacious single drug therapy (DTIC); it also emphasizes the necessity of randomized studies so that valuable comparisons may be done.
Related Publications
J Chauvergne, and
B Clavel, and
T Klein, and
E Pommatau
January 1979,
Zentralblatt fur Chirurgie,
J Chauvergne, and
B Clavel, and
T Klein, and
E Pommatau
December 1982,
La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
J Chauvergne, and
B Clavel, and
T Klein, and
E Pommatau
December 1978,
Wiener klinische Wochenschrift,
J Chauvergne, and
B Clavel, and
T Klein, and
E Pommatau
August 1977,
Cancer treatment reports,
J Chauvergne, and
B Clavel, and
T Klein, and
E Pommatau
September 1976,
Cancer treatment reports,
J Chauvergne, and
B Clavel, and
T Klein, and
E Pommatau
January 1978,
Acta haematologica,
J Chauvergne, and
B Clavel, and
T Klein, and
E Pommatau
April 1976,
Cancer,
J Chauvergne, and
B Clavel, and
T Klein, and
E Pommatau
June 1988,
Cancer,
J Chauvergne, and
B Clavel, and
T Klein, and
E Pommatau
February 1982,
Zeitschrift fur Hautkrankheiten,
J Chauvergne, and
B Clavel, and
T Klein, and
E Pommatau
November 1977,
Dermatologische Monatschrift,
